- Visibility6
- Citations0
- Sentiment50
- Site quality73
- AI readiness21
AI assistants rarely name Krystal Biotech in their answers, doing so just once out of 60 answers. Its overall score is 26 out of 100, which ranks 1,668th of 2,047 companies. The company's website passes 3 of 14 technical checks for AI tools.
We asked 15 unbranded questions about the technology market: none named Krystal Biotech. AI assistants named it in 1 of 60 answers (1.7%). The typical technology company is named in 10.0% of answers. By how often it is named, Krystal Biotech ranks 211 of 273 in its sector.
Named fewer than three times in total. Read this as a sign that AI assistants rarely bring this company up, not as an exact comparison with its rivals.
Every dot is a company in the study. Hover one to see it; click to open its report.
This companySame sectorEvery other companyNever named
Five parts, each scored out of 100.
How often AI assistants name the company
How often AI uses the company's own website as a source
How positively AI describes the company
How well built the website's own pages are
How easily AI tools can read and use the website
Visibility is calculated from the answers on this page. How the score is built.
273 companies in this sector. The line on each bar is the typical company.
An answer that names the company
“Who is a good candidate for redosable gene therapy in the treatment of severe genetic conditions?”
Redosable gene therapy is a promising approach for treating severe genetic conditions, especially those that may require repeated administration of the therapeutic gene. While the field is still evolving, certain characteristics define good candidates for this type of treatment.
Diseases and Conditions:
Dystrophic Epidermolysis Bullosa (DEB): This rare and severe genetic skin disease is a prime example of a condition for which redosable gene therapy has shown success. VYJUVEK, the first FDA-approved redosable gene therapy, treats DEB by delivering functional copies of the COL7A1 …
The AI’s answer as we received it, shortened and not checked for accuracy.
How the mentions in these answers were split between this company and its rivals
Answers naming it, out of answers received
What this website publishes for an AI agent to read, use and buy from, on a scale of six levels.
- 0
- 1
- 2
- 3
- 4
- 5
Level 1: Basic web presence. Two of robots.txt, a sitemap and Link headers are in place.
- Content Signals
Not by itself. Krystal Biotech publishes none of the purchase protocols we look for. An agent would have to click through the checkout like a person.
- UCPNot present
- ACPNot present
- AP2Not present
- x402Not present
- MPPNot present
The shop runs on WooCommerce.
Show every check, for your technical teamHide the checks
- study: 92.0%robots.txtPassed
A valid robots.txt with crawl rules at the site root.
- study: 86.8%SitemapPartly met
Serve an XML sitemap and reference it from robots.txt.
- study: 0.3%Link headersNot met
Send Link headers such as rel="api-catalog" or rel="describedby" on the homepage.
- study: 5.5%DNS for AI DiscoveryNot present
Advertise agent endpoints with SVCB records under _agents.
- study: 1.9%Markdown negotiationNot met
Return a markdown version when asked with Accept: text/markdown, for example at the CDN.
- study: 25.1%llms.txtNot met
Publish an llms.txt with a short summary and the key links.
- study: 93.4%AI bot rulesPartly met
Add explicit robots.txt groups for the main AI crawlers.
- study: 1.4%Content SignalsNot met
Add a Content-Signal line for search, ai-input and ai-train to robots.txt.
- study: 0.2%Web Bot AuthNot present
Only relevant if you run your own agents or crawlers: publish a signing key directory.
- study: 0.3%API CatalogNot met
List public APIs in a linkset at /.well-known/api-catalog.
- study: 11.8%OAuth discoveryNot met
Publish OpenID Connect or OAuth server metadata under /.well-known.
- study: 10.3%OAuth Protected ResourceNot met
Serve protected resource metadata at /.well-known/oauth-protected-resource.
- study: 0.0%auth.mdNot met
Publish an auth.md describing how agents sign in.
- study: 0.2%MCP Server CardNot met
Offer an MCP server and publish its server card under /.well-known.
- study: 0.1%A2A Agent CardNot met
Publish an agent card at /.well-known/agent-card.json.
- study: 0.2%Agent SkillsNot met
Publish a skills index with the main tasks agents can do.
- study: 33.7%WebMCPCould not check
Register key actions such as search or cart as WebMCP tools.
- study: 0.1%ARD manifestNot met
Publish an ai-catalog.json listing every agent interface.
Score 24 of 100 · 97% of checks could run · checked on October 5, 2026 · www.krystalbio.com · 2,047 companies scanned
3 of 14 passed. This list is for your technical team. The percentage is how many companies in the study pass each check.
These 14 checks ran during the audit and are what the AI readiness part of the overall score counts. The scan above ran later and is stricter on Link headers and Markdown, so a check can pass here and not there.
Show the 14 checksHide them
- Passedrobots.txt publishedstudy: 85.0%
- Not metXML sitemapstudy: 73.2%
- PassedHTTP Link headers (RFC 8288)study: 29.0%
- Not metMarkdown content negotiationstudy: 8.3%
- Not metllms.txt publishedstudy: 21.7%
- PassedToken budget (page weight)study: 95.2%
- Not metExplicit AI bot rulesstudy: 13.0%
- Not metAPI Catalog (.well-known/api-catalog)study: 0.2%
- Not metOAuth Authorization Server discoverystudy: 10.1%
- Not metOAuth Protected Resource discoverystudy: 9.3%
- Not metMCP Server Cardstudy: 0.0%
- Not metA2A Agent Cardstudy: 0.0%
- Not metWebMCP toolsstudy: 4.2%
- Not metAgent Skills declaredstudy: 0.0%
This website sets no rules for any AI crawler by name, like 84% of the websites whose rules we could read. Every AI crawler follows its general rules.
- GPTBotpartly
- ClaudeBotpartly
- Anthropic-AIpartly
- Google-Extendedpartly
- Applebot-Extendedpartly
- Meta-ExternalAgentpartly
- FacebookBotpartly
- Bytespiderpartly
- CCBotpartly
- Diffbotpartly
- Omgilibotpartly
- OAI-SearchBotpartly
- Claude-SearchBotpartly
- PerplexityBotpartly
- Applebotpartly
- Amazonbotpartly
- YouBotpartly
- ChatGPT-Userpartly
- Claude-Userpartly
- Perplexity-Userpartly
- DuckAssistBotpartly
- MistralAI-Userpartly
Read from the website’s own rules file (robots.txt). An asterisk marks a crawler the file names. The rest follow its general rules. “Partly” means only some pages are blocked.
How many times each website was listed as a source in these answers
In the study as US-listed.
- What factors influence the cost of gene therapy for rare diseases in the U.S. healthcare system?
- How can gene therapy help manage symptoms in patients with unmet medical needs?
- What are alternatives to gene therapy for managing life-threatening inherited diseases?
- Are redosable gene therapies worth considering for families affected by hereditary conditions?
- How do you address immune responses or other complications from gene therapy?
- How do redosable gene therapies compare to single-dose options for treating severe genetic disorders?
- How can patients find financial support for genetic medicine treatments?
- Is investing in gene therapy a good choice for patients with limited or no approved treatments?
- Which gene therapy approaches are available for life-threatening genetic conditions?
- Gene therapy versus traditional treatments for rare disease management—what are the main differences?
- What new advancements are happening in genetic medicine for rare and severe diseases?
- What are common challenges patients face after receiving genetic medicine for rare diseases?
- Who is a good candidate for redosable gene therapy in the treatment of severe genetic conditions?
- What are the best gene therapy options for rare genetic diseases in the United States?
- Which non-gene therapy approaches are available for rare genetic disorders without approved therapies?
Columns, left to right: OpenAI, Claude, Perplexity, Gemini. The AI assistants often disagree. Across the study, on 40% of the questions where a company is named, only one of the four names it.